跳转至内容
Merck
CN
所有图片(1)

文件

MAB4162

Sigma-Aldrich

抗-MDR1抗体，细胞外人类特异性Pgp，克隆号MM4.17

clone MM4.17, Chemicon®, from mouse

登录查看公司和协议定价
所有图片(1)
别名:
P-glycoprotein, CD243, p170, Pgp
UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

300

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

MM4.17, monoclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

flow cytometry: suitable
immunohistochemistry: suitable

同位素/亚型

IgG2aκ

NCBI登记号

NM_000927.3

UniProt登记号

P08183

运输

wet ice

相关类别

特异性

识别细胞外Pgp结构域的一个表位，并在活（完整）人类MDR细胞中检测低水平的Pgp表达（Cianfriglia，2002）。 使用不同的技术将表位定位到单氨基酸水平（Cianfriglia，1994和Poloni，1995）。

应用

抗-MDR1抗体，细胞外人类特异性Pgp，克隆号MM4.17是一种抗MDR1抗体，用于FC、IH。
流式细胞术

丙酮固定石蜡包埋切片的免疫组化

共聚焦和电子显微镜

ELISA

最佳工作稀释度必须由最终用户进行确定。

外形

形式：纯化

其他说明

浓度：请参考批次特异性浓缩物的检验报告。

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Marine Chartrain et al.
PloS one, 7(5), e36762-e36762 (2012-06-08)
Metastatic melanoma is the most aggressive skin cancer. Recently, phenotypically distinct subpopulations of tumor cells were identified. Among them, ABCB5-expressing cells were proposed to display an enhanced tumorigenicity with stem cell-like properties. In addition, ABCB5(+) cells are thought to participate
Paola Turella et al.
The Journal of biological chemistry, 281(33), 23725-23732 (2006-06-14)
The new glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) is cytotoxic toward P-glycoprotein-overexpressing tumor cell lines, i.e. CEM-VBL10, CEM-VBL100, and U-2 OS/DX580. The mechanism of cell death triggered by NBDHEX has been deeply investigated in leukemia cell lines. Kinetic data indicate a
Jingwei Zhang et al.
British journal of pharmacology, 165(1), 120-134 (2011-05-28)
Intracellular pharmacokinetics of anticancer drugs in multi-drug resistance (MDR) cancer cells is hugely important in the evaluation and improvement of drug efficacy. By using adriamycin as a probe drug in MDR cancer cells, we developed a cellular pharmacokinetic-pharmacodynamic (PK-PD) model
Masahiro Yasunaga et al.
Scientific reports, 4, 4852-4852 (2014-05-02)
The treatment of colorectal cancer (CRC) might be improved by the identification of a signalling pathway that could be targeted with novel therapeutics. The results of this study indicate that the taurine transporter SLC6A6 is highly expressed in CRC cells
Wanyuan Chen et al.
Oncology reports, 41(1), 67-76 (2018-10-27)
Pancreatic cancer (PC) is a lethal solid malignancy with resistance to traditional chemotherapy. Recently, considerable studies have demonstrated the ubiquitous antitumor properties of gene therapy mediated by the oncolytic vaccinia virus. The second mitochondrial‑derived activator of caspase (Smac) has been

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门